Intra-Cellular Therapies, Inc.Equity-NMS: ITCI
Equity-NMS: ITCI
$91.25
+0.71
(9 Nov)
Loading Chart
1D
1W
3M
1Y
5Y
Previous close
$91.25
Open
$91.25
Today’s high
$91.40
Today’s low
$89.28
52W low
$52.88
52W high
$91.68
1Y
70.69%
5Y
56.91%
EPS (TTM)
-0.88
Shares O/S
106.02M
Market cap
9.67B
Insights
No insights found for this stock
Compare with other stock
Price
1D
PE
Market cap
About Intra-Cellular Therapies, Inc.

Intra-Cellular Therapies, Inc. is a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders. The Company leverages intracellular approach to develop treatments for people living with complex psychiatric and neurologic diseases. The Company’s product, CAPLYTA (lumateperone), is an oral, once daily atypical antipsychotic approved in adults for the treatment of schizophrenia and the treatment of depressive episodes associated with bipolar I or II disorder (bipolar depression) as monotherapy and as adjunctive therapy with lithium or valproate.

Its pipeline includes several product candidates in clinical development and additional product candidates in non-clinical testing, such as ITI-1284-ODT-SL program, Phosphodiesterase type I inhibitor (PDE1) program, ITI-333 program, and ITI-1500 Non-Hallucinogenic Psychedelic program. ITI-1284 is a deuterated form of lumateperone, a new chemical entity. .


FAQs

Can I buy Intra-Cellular Therapies, Inc. shares in India?
How to buy Intra-Cellular Therapies, Inc. shares in India?
What is the share price of Intra-Cellular Therapies, Inc.?
What is the Market Capitalization of Intra-Cellular Therapies, Inc.?
What is the PE ratio of Intra-Cellular Therapies, Inc.?
Is Intra-Cellular Therapies, Inc. a good stock to buy?
In which sector / industry does Intra-Cellular Therapies, Inc. operate?